Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr Reddy’s Laboratories enters into Colombian market to sell cancer drugs

Date: 08-10-2016

Dr Reddy’s Laboratories has forayed into the Colombian market with its portfolio of high quality and affordable medicines for cancer drugs.

The Hyderabad-based firm operates in all major markets including the US, Russia, CIS countries and Europe with a workforce of above 20,000 employees. Currently, Dr Reddy's is the second largest generic oncology injectable company by value in the US and leading generic oncology firm in India.